Compile Data Set for Download or QSAR
Report error Found 324 Enz. Inhib. hit(s) with all data for entry = 8387
TargetFocal adhesion kinase 1(Human)
Centaurus Biopharma

US Patent
LigandPNGBDBM245597(US9428508, 52)
Affinity DataIC50: 20nMAssay Description:To measure inhibitory activity of FAK/PYK2 inhibitors, compounds were first prepare as a 1 mM stock in 100% DMSO and 3-fold serial dilution was perfo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
US Patent

TargetFocal adhesion kinase 1(Human)
Centaurus Biopharma

US Patent
LigandPNGBDBM245598(US9428508, 53)
Affinity DataIC50: 20nMAssay Description:To measure inhibitory activity of FAK/PYK2 inhibitors, compounds were first prepare as a 1 mM stock in 100% DMSO and 3-fold serial dilution was perfo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Centaurus Biopharma

US Patent
LigandPNGBDBM245692(US9428508, 147)
Affinity DataIC50: 20nMAssay Description:To measure inhibitory activity of FAK/PYK2 inhibitors, compounds were first prepare as a 1 mM stock in 100% DMSO and 3-fold serial dilution was perfo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Centaurus Biopharma

US Patent
LigandPNGBDBM245689(US9428508, 144)
Affinity DataIC50: 20nMAssay Description:To measure inhibitory activity of FAK/PYK2 inhibitors, compounds were first prepare as a 1 mM stock in 100% DMSO and 3-fold serial dilution was perfo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
US Patent

TargetFocal adhesion kinase 1(Human)
Centaurus Biopharma

US Patent
LigandPNGBDBM245585(US9428508, 40 | US9428508, 46)
Affinity DataIC50: 20nMAssay Description:To measure inhibitory activity of FAK/PYK2 inhibitors, compounds were first prepare as a 1 mM stock in 100% DMSO and 3-fold serial dilution was perfo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Centaurus Biopharma

US Patent
LigandPNGBDBM245685(US9428508, 140)
Affinity DataIC50: 20nMAssay Description:To measure inhibitory activity of FAK/PYK2 inhibitors, compounds were first prepare as a 1 mM stock in 100% DMSO and 3-fold serial dilution was perfo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Centaurus Biopharma

US Patent
LigandPNGBDBM245686(US9428508, 141)
Affinity DataIC50: 20nMAssay Description:To measure inhibitory activity of FAK/PYK2 inhibitors, compounds were first prepare as a 1 mM stock in 100% DMSO and 3-fold serial dilution was perfo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
US Patent

TargetFocal adhesion kinase 1(Human)
Centaurus Biopharma

US Patent
LigandPNGBDBM245603(US9428508, 58)
Affinity DataIC50: 20nMAssay Description:To measure inhibitory activity of FAK/PYK2 inhibitors, compounds were first prepare as a 1 mM stock in 100% DMSO and 3-fold serial dilution was perfo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Centaurus Biopharma

US Patent
LigandPNGBDBM245697(US9428508, 152)
Affinity DataIC50: 20nMAssay Description:To measure inhibitory activity of FAK/PYK2 inhibitors, compounds were first prepare as a 1 mM stock in 100% DMSO and 3-fold serial dilution was perfo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
US Patent

TargetFocal adhesion kinase 1(Human)
Centaurus Biopharma

US Patent
LigandPNGBDBM245601(US9428508, 56)
Affinity DataIC50: 20nMAssay Description:To measure inhibitory activity of FAK/PYK2 inhibitors, compounds were first prepare as a 1 mM stock in 100% DMSO and 3-fold serial dilution was perfo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Centaurus Biopharma

US Patent
LigandPNGBDBM245695(US9428508, 150)
Affinity DataIC50: 20nMAssay Description:To measure inhibitory activity of FAK/PYK2 inhibitors, compounds were first prepare as a 1 mM stock in 100% DMSO and 3-fold serial dilution was perfo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
US Patent

TargetFocal adhesion kinase 1(Human)
Centaurus Biopharma

US Patent
LigandPNGBDBM245602(US9428508, 57)
Affinity DataIC50: 20nMAssay Description:To measure inhibitory activity of FAK/PYK2 inhibitors, compounds were first prepare as a 1 mM stock in 100% DMSO and 3-fold serial dilution was perfo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Centaurus Biopharma

US Patent
LigandPNGBDBM245696(US9428508, 151)
Affinity DataIC50: 20nMAssay Description:To measure inhibitory activity of FAK/PYK2 inhibitors, compounds were first prepare as a 1 mM stock in 100% DMSO and 3-fold serial dilution was perfo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
US Patent

TargetFocal adhesion kinase 1(Human)
Centaurus Biopharma

US Patent
LigandPNGBDBM245599(US9428508, 54)
Affinity DataIC50: 20nMAssay Description:To measure inhibitory activity of FAK/PYK2 inhibitors, compounds were first prepare as a 1 mM stock in 100% DMSO and 3-fold serial dilution was perfo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Centaurus Biopharma

US Patent
LigandPNGBDBM245693(US9428508, 148)
Affinity DataIC50: 20nMAssay Description:To measure inhibitory activity of FAK/PYK2 inhibitors, compounds were first prepare as a 1 mM stock in 100% DMSO and 3-fold serial dilution was perfo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
US Patent

TargetFocal adhesion kinase 1(Human)
Centaurus Biopharma

US Patent
LigandPNGBDBM245600(US9428508, 55)
Affinity DataIC50: 20nMAssay Description:To measure inhibitory activity of FAK/PYK2 inhibitors, compounds were first prepare as a 1 mM stock in 100% DMSO and 3-fold serial dilution was perfo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
US Patent

TargetFocal adhesion kinase 1(Human)
Centaurus Biopharma

US Patent
LigandPNGBDBM245614(US9428508, 69)
Affinity DataIC50: 20nMAssay Description:To measure inhibitory activity of FAK/PYK2 inhibitors, compounds were first prepare as a 1 mM stock in 100% DMSO and 3-fold serial dilution was perfo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
US Patent

TargetFocal adhesion kinase 1(Human)
Centaurus Biopharma

US Patent
LigandPNGBDBM245611(US9428508, 66)
Affinity DataIC50: 20nMAssay Description:To measure inhibitory activity of FAK/PYK2 inhibitors, compounds were first prepare as a 1 mM stock in 100% DMSO and 3-fold serial dilution was perfo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
US Patent

TargetFocal adhesion kinase 1(Human)
Centaurus Biopharma

US Patent
LigandPNGBDBM245609(US9428508, 64)
Affinity DataIC50: 20nMAssay Description:To measure inhibitory activity of FAK/PYK2 inhibitors, compounds were first prepare as a 1 mM stock in 100% DMSO and 3-fold serial dilution was perfo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
US Patent

TargetFocal adhesion kinase 1(Human)
Centaurus Biopharma

US Patent
LigandPNGBDBM245610(US9428508, 65)
Affinity DataIC50: 20nMAssay Description:To measure inhibitory activity of FAK/PYK2 inhibitors, compounds were first prepare as a 1 mM stock in 100% DMSO and 3-fold serial dilution was perfo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
US Patent

TargetFocal adhesion kinase 1(Human)
Centaurus Biopharma

US Patent
LigandPNGBDBM245607(US9428508, 62)
Affinity DataIC50: 20nMAssay Description:To measure inhibitory activity of FAK/PYK2 inhibitors, compounds were first prepare as a 1 mM stock in 100% DMSO and 3-fold serial dilution was perfo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Centaurus Biopharma

US Patent
LigandPNGBDBM245701(US9428508, 156)
Affinity DataIC50: 20nMAssay Description:To measure inhibitory activity of FAK/PYK2 inhibitors, compounds were first prepare as a 1 mM stock in 100% DMSO and 3-fold serial dilution was perfo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
US Patent

TargetFocal adhesion kinase 1(Human)
Centaurus Biopharma

US Patent
LigandPNGBDBM245608(US9428508, 63)
Affinity DataIC50: 20nMAssay Description:To measure inhibitory activity of FAK/PYK2 inhibitors, compounds were first prepare as a 1 mM stock in 100% DMSO and 3-fold serial dilution was perfo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
US Patent

TargetProtein-tyrosine kinase 2-beta(Human)
Centaurus Biopharma

US Patent
LigandPNGBDBM245702(US9428508, 157)
Affinity DataIC50: 20nMAssay Description:To measure inhibitory activity of FAK/PYK2 inhibitors, compounds were first prepare as a 1 mM stock in 100% DMSO and 3-fold serial dilution was perfo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
US Patent

TargetFocal adhesion kinase 1(Human)
Centaurus Biopharma

US Patent
LigandPNGBDBM245621(US9428508, 76)
Affinity DataIC50: 20nMAssay Description:To measure inhibitory activity of FAK/PYK2 inhibitors, compounds were first prepare as a 1 mM stock in 100% DMSO and 3-fold serial dilution was perfo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
US Patent

TargetFocal adhesion kinase 1(Human)
Centaurus Biopharma

US Patent
LigandPNGBDBM245619(US9428508, 74)
Affinity DataIC50: 20nMAssay Description:To measure inhibitory activity of FAK/PYK2 inhibitors, compounds were first prepare as a 1 mM stock in 100% DMSO and 3-fold serial dilution was perfo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
US Patent

TargetFocal adhesion kinase 1(Human)
Centaurus Biopharma

US Patent
LigandPNGBDBM245620(US9428508, 75)
Affinity DataIC50: 20nMAssay Description:To measure inhibitory activity of FAK/PYK2 inhibitors, compounds were first prepare as a 1 mM stock in 100% DMSO and 3-fold serial dilution was perfo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
US Patent

TargetFocal adhesion kinase 1(Human)
Centaurus Biopharma

US Patent
LigandPNGBDBM245617(US9428508, 72)
Affinity DataIC50: 20nMAssay Description:To measure inhibitory activity of FAK/PYK2 inhibitors, compounds were first prepare as a 1 mM stock in 100% DMSO and 3-fold serial dilution was perfo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
US Patent

TargetFocal adhesion kinase 1(Human)
Centaurus Biopharma

US Patent
LigandPNGBDBM245618(US9428508, 73)
Affinity DataIC50: 20nMAssay Description:To measure inhibitory activity of FAK/PYK2 inhibitors, compounds were first prepare as a 1 mM stock in 100% DMSO and 3-fold serial dilution was perfo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
US Patent

TargetFocal adhesion kinase 1(Human)
Centaurus Biopharma

US Patent
LigandPNGBDBM245615(US9428508, 70)
Affinity DataIC50: 20nMAssay Description:To measure inhibitory activity of FAK/PYK2 inhibitors, compounds were first prepare as a 1 mM stock in 100% DMSO and 3-fold serial dilution was perfo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
US Patent

TargetFocal adhesion kinase 1(Human)
Centaurus Biopharma

US Patent
LigandPNGBDBM245630(US9428508, 85)
Affinity DataIC50: 20nMAssay Description:To measure inhibitory activity of FAK/PYK2 inhibitors, compounds were first prepare as a 1 mM stock in 100% DMSO and 3-fold serial dilution was perfo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
US Patent

TargetFocal adhesion kinase 1(Human)
Centaurus Biopharma

US Patent
LigandPNGBDBM245627(US9428508, 82)
Affinity DataIC50: 20nMAssay Description:To measure inhibitory activity of FAK/PYK2 inhibitors, compounds were first prepare as a 1 mM stock in 100% DMSO and 3-fold serial dilution was perfo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
US Patent

TargetFocal adhesion kinase 1(Human)
Centaurus Biopharma

US Patent
LigandPNGBDBM245628(US9428508, 83)
Affinity DataIC50: 20nMAssay Description:To measure inhibitory activity of FAK/PYK2 inhibitors, compounds were first prepare as a 1 mM stock in 100% DMSO and 3-fold serial dilution was perfo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
US Patent

TargetFocal adhesion kinase 1(Human)
Centaurus Biopharma

US Patent
LigandPNGBDBM245625(US9428508, 80)
Affinity DataIC50: 20nMAssay Description:To measure inhibitory activity of FAK/PYK2 inhibitors, compounds were first prepare as a 1 mM stock in 100% DMSO and 3-fold serial dilution was perfo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
US Patent

TargetFocal adhesion kinase 1(Human)
Centaurus Biopharma

US Patent
LigandPNGBDBM245626(US9428508, 81)
Affinity DataIC50: 20nMAssay Description:To measure inhibitory activity of FAK/PYK2 inhibitors, compounds were first prepare as a 1 mM stock in 100% DMSO and 3-fold serial dilution was perfo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
US Patent

TargetFocal adhesion kinase 1(Human)
Centaurus Biopharma

US Patent
LigandPNGBDBM245623(US9428508, 78)
Affinity DataIC50: 20nMAssay Description:To measure inhibitory activity of FAK/PYK2 inhibitors, compounds were first prepare as a 1 mM stock in 100% DMSO and 3-fold serial dilution was perfo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
US Patent

TargetFocal adhesion kinase 1(Human)
Centaurus Biopharma

US Patent
LigandPNGBDBM245624(US9428508, 79)
Affinity DataIC50: 20nMAssay Description:To measure inhibitory activity of FAK/PYK2 inhibitors, compounds were first prepare as a 1 mM stock in 100% DMSO and 3-fold serial dilution was perfo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
US Patent

TargetFocal adhesion kinase 1(Human)
Centaurus Biopharma

US Patent
LigandPNGBDBM245637(US9428508, 92)
Affinity DataIC50: 20nMAssay Description:To measure inhibitory activity of FAK/PYK2 inhibitors, compounds were first prepare as a 1 mM stock in 100% DMSO and 3-fold serial dilution was perfo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
US Patent

TargetFocal adhesion kinase 1(Human)
Centaurus Biopharma

US Patent
LigandPNGBDBM245638(US9428508, 93)
Affinity DataIC50: 20nMAssay Description:To measure inhibitory activity of FAK/PYK2 inhibitors, compounds were first prepare as a 1 mM stock in 100% DMSO and 3-fold serial dilution was perfo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
US Patent

TargetFocal adhesion kinase 1(Human)
Centaurus Biopharma

US Patent
LigandPNGBDBM245635(US9428508, 90)
Affinity DataIC50: 20nMAssay Description:To measure inhibitory activity of FAK/PYK2 inhibitors, compounds were first prepare as a 1 mM stock in 100% DMSO and 3-fold serial dilution was perfo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
US Patent

TargetFocal adhesion kinase 1(Human)
Centaurus Biopharma

US Patent
LigandPNGBDBM245634(US9428508, 89)
Affinity DataIC50: 20nMAssay Description:To measure inhibitory activity of FAK/PYK2 inhibitors, compounds were first prepare as a 1 mM stock in 100% DMSO and 3-fold serial dilution was perfo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
US Patent

TargetFocal adhesion kinase 1(Human)
Centaurus Biopharma

US Patent
LigandPNGBDBM245631(US9428508, 86)
Affinity DataIC50: 20nMAssay Description:To measure inhibitory activity of FAK/PYK2 inhibitors, compounds were first prepare as a 1 mM stock in 100% DMSO and 3-fold serial dilution was perfo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
US Patent

TargetFocal adhesion kinase 1(Human)
Centaurus Biopharma

US Patent
LigandPNGBDBM245632(US9428508, 87)
Affinity DataIC50: 20nMAssay Description:To measure inhibitory activity of FAK/PYK2 inhibitors, compounds were first prepare as a 1 mM stock in 100% DMSO and 3-fold serial dilution was perfo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
US Patent

TargetFocal adhesion kinase 1(Human)
Centaurus Biopharma

US Patent
LigandPNGBDBM245645(US9428508, 100)
Affinity DataIC50: 20nMAssay Description:To measure inhibitory activity of FAK/PYK2 inhibitors, compounds were first prepare as a 1 mM stock in 100% DMSO and 3-fold serial dilution was perfo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
US Patent

TargetFocal adhesion kinase 1(Human)
Centaurus Biopharma

US Patent
LigandPNGBDBM245646(US9428508, 101)
Affinity DataIC50: 20nMAssay Description:To measure inhibitory activity of FAK/PYK2 inhibitors, compounds were first prepare as a 1 mM stock in 100% DMSO and 3-fold serial dilution was perfo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
US Patent

TargetFocal adhesion kinase 1(Human)
Centaurus Biopharma

US Patent
LigandPNGBDBM245643(US9428508, 98)
Affinity DataIC50: 20nMAssay Description:To measure inhibitory activity of FAK/PYK2 inhibitors, compounds were first prepare as a 1 mM stock in 100% DMSO and 3-fold serial dilution was perfo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
US Patent

TargetFocal adhesion kinase 1(Human)
Centaurus Biopharma

US Patent
LigandPNGBDBM245641(US9428508, 96)
Affinity DataIC50: 20nMAssay Description:To measure inhibitory activity of FAK/PYK2 inhibitors, compounds were first prepare as a 1 mM stock in 100% DMSO and 3-fold serial dilution was perfo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
US Patent

TargetFocal adhesion kinase 1(Human)
Centaurus Biopharma

US Patent
LigandPNGBDBM245640(US9428508, 95)
Affinity DataIC50: 20nMAssay Description:To measure inhibitory activity of FAK/PYK2 inhibitors, compounds were first prepare as a 1 mM stock in 100% DMSO and 3-fold serial dilution was perfo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
US Patent

TargetFocal adhesion kinase 1(Human)
Centaurus Biopharma

US Patent
LigandPNGBDBM245651(US9428508, 106)
Affinity DataIC50: 20nMAssay Description:To measure inhibitory activity of FAK/PYK2 inhibitors, compounds were first prepare as a 1 mM stock in 100% DMSO and 3-fold serial dilution was perfo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
US Patent

TargetFocal adhesion kinase 1(Human)
Centaurus Biopharma

US Patent
LigandPNGBDBM245652(US9428508, 107)
Affinity DataIC50: 20nMAssay Description:To measure inhibitory activity of FAK/PYK2 inhibitors, compounds were first prepare as a 1 mM stock in 100% DMSO and 3-fold serial dilution was perfo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
US Patent

Displayed 1 to 50 (of 324 total ) | Next | Last >>
Jump to: